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Abstract
Background: Casein kinase 1 delta (CK1d) phosphorylates many key proteins playing important roles in such biological
processes as cell growth, differentiation, apoptosis, circadian rhythm and vesicle transport. Furthermore, deregulation of
CK1d has been linked to neurodegenerative diseases and cancer. In this study, the cell specific distribution of CK1d in
various tissues and organs of young adult BALB/c mice was analysed by immunohistochemistry.
Methodology/Principal Findings: Immunohistochemical staining of CK1d was performed using three different antibodies
against CK1d. A high expression of CK1d was found in a variety of tissues and organ systems and in several cell types of
endodermal, mesodermal and ectodermal origin.
Conclusions: These results give an overview of the cell-type specific expression of CK1d in different organs under normal
conditions. Thus, they provide evidence for possible cell-type specific functions of CK1d, where CK1d can interact with and
modulate the activity of key regulator proteins by site directed phosphorylation. Furthermore, they provide the basis for
future analyses of CK1d in these tissues.
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Introduction
The mammalian members of the CK1 (formerly casein kinase
1) family, namely CK1a, b, c1–3, d and e and their various splice
variants, are ubiquitiously expressed. They are highly conserved
within their kinase domains, but they significantly differ in lengths
and primary structures of their regulatory N- and C-terminal non-
catalytic domains (reviewed in [1,2]). Within the cell CK1 isoforms
are found in the nucleus, the cytoplasm and at the plasma
membrane (reviewed in [1,2]). They are able to phosphorylate
many different substrates bearing either a canonical or non-
canonical consensus sequence [1,3–5]. As a result, they can
modulate the activity of key regulator proteins involved in
biological processes such as cell differentiation [6–11], cell
proliferation, apoptosis [12–16], circadian rhythm [17], chromo-
some segregation [18–21], and vesicle transport [19,20,22].
Considering the importance of CK1-mediated signals, it is obvious
that mutations and/or changes in the activity of CK1 isoforms,
especially of CK1d and e, or mutations of CK1 specific
phosphorylation sites within their substrates can be pathogenic,
leading to neurodegenerative diseases [23–26], sleeping disorders
[27–30], and/or cancer [2,31–36].
Recently, interest has increased to clarify the physiological
functions of CK1d. Previous studies on mRNA and protein level
revealed an ubiquitous distribution of CK1d [35,37,38]. Further-
more, differences in the activity of CK1d in tissues with similar
expression levels indicate that posttranslational modifications,
especially site-specific phosphorylation, play an important role in
regulating the activity of CK1d ([2] and references therein, [39]).
In addition, it has been suggested that CK1d plays an important
role in regulating several aspects of lymphocyte physiology [35].
In this report we use immunohistrochemistry (IHC) to
determine the tissue and cell-type specific distribution of CK1d
in healthy mice. Providing an anatomical fundament, our results
may contribute to better understanding the possible cell-type
specific functions of CK1d under physiological conditions.
Results
Fixation and immunolabelling
Previously, we have shown that CK1d protein is ubiquitously
expressed in mouse tissues and organs. Furthermore, differences
in protein and functional activity levels have been detected [35]. In
this study, the cell-type specific expression patterns of CK1d in
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immediately induced upon cellular stress [40], it is crucial to
obtain an efficient and fast fixation of the tissue. To optimise the
immunohistochemical detection of CK1d the effects of different
fixations, fixatives, blocking solutions, and antigen demasking
procedures were tested (see Tables 1–3). In addition, the suitability
and specificity of three CK1d specific antibodies (NC10, 108,
ab10877) were characterised (Figures 1 and 2, see Material and
Methods section, Behrend and co-workers [19], and Sto ¨ter and co-
workers [36]).
Different modes of fixation (i.e. immersion or perfusion) and
various fixation solutions were compared with respect to antigen
preservation, CK1d staining intensity, and the preservation of
tissue morphology in paraffin embedded tissues. As shown in
Table 1 optimal antigen preservation was obtained with acetic
acid formalin or Bouin’s fixative. Comparison of perfusion with
immersion fixation revealed only slight regional differences in the
CK1d staining intensity, and in the preservation of the
morphology, especially when Bouin’s solution, acid formalin or
neutral buffered formalin were used as fixatives.
Different antigen retrievals were required to expose the
particular CK1d epitope recognised by each of the three different
CK1d specific antibodies in paraffin-embedded tissues. Best
staining results for NC10 were obtained using TUF (Target
Unmasking Fluid, the composition is not disclosed by Kreotech) at
90uC in a microwave oven, whereas the primary polyclonal
antibodies PAb108 and PAb10877 showed better immunoreac-
tivity by antigen retrieval in citric buffer in a microwave oven.
PAb108 recognised CK1d in paraffin-embedded tissues only when
sections were heated in a pressure cooker inside a microwave oven
(Table 2).
Staining of myelin sheets in neuronal tissues with diaminoben-
cidine as a colour substrate gave inconsistent results, ranging from
strongly positive to negative. Since diaminobencidine staining has
Table 2. Heat induced antigen demasking.
Demasking solution Pab NC10 Pab 108 Pab ab10877
TUF (Target unmasking fluid) (Kreatech)
N pH 5,70 +++ 2 to 2/++
Citra Plus 106(Biogenex)
N pH 6,0 ++ 2/+ +++
+++(with autoclave in microwave)
AR-10 solution 106(Biogenex)
N pH 10,7 2/+ 2 to 2/+ 2/+
Tris-Puffer
N pH 7,3 + 2 to 2/++
Sections of paraffin-embedded tissue were used to test the ability of various solutions to demask the antigen. The detection of CK1d was evaluated by the specific
colour intensity of the applied antibody using the scaling mentioned in the table: 2 no specific labelling, 2/+ pale; + weak, ++moderate, +++strong labelling.
doi:10.1371/journal.pone.0004174.t002
Table 1. Effect of different fixation agents and fixation methods on antigen detection.
fixation solution antigen preservation morphology number of animals
perfusion fixation 8
N Bouin solution ++ (+) +++ 2
N Acid formalin (4%) ++(+) +++ 3
N Neutral buffered formalin (10%) ++ +++ 3
immersion fixation 24
N Bouin solution ++ ++(+)2
N acid formalin (4%) ++ ++(+)6
N neutral buffered formalin (10%) + (+) ++(+)6
N Carnoy-fixation 22 ++ 2
N Zinc-fixation + (+) 2 2
N Glyo Fixx (Shandon) ++ + 2
N Zinc Formal-Fixx (Shandon) (+) ++ 2
N Notox Histological Fixative (Quartett) 2/++ + 2
To establish the immunohistochemical detection of CK1d several fixation methods and fixatives had been used. Paraffin embedded tissue sections were immunostained
for CK1d using different fixation solutions and fixation methods. Comparison of the perfusion with the immersion fixation method revealed only slight regional
differences in the preservation of CK1d and in the morphology of the tissue especially when acidic formalin or Bouin’s fluid were used as fixatives. 2 no effect on
antigen detection or morphology; + weak effect on antigen detection or morphology; ++ medium effect on antigen detection or morphology ; +++ strong effect on
antigen detection or morphology. (+) indicates intermediate effect, for instance ++(+) indicates intermediate level between medium and strong effect.
doi:10.1371/journal.pone.0004174.t001
IHC Analysis of CK1d
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considered the myelin staining as artificial.
When polyclonal CK1d specific antibodies raised in rabbit
(NC10, PAb108) or goat (ab10877) were compared, similar
reactivities were detected in frozen and paraffin embedded tissues
(see Figure 2 for an example). However, the tissue morphology was
far better preserved in paraffin sections when compared to
cryosections. Therefore, we decided to carry out all further
immunostainings on paraffin embedded tissues.
Cell specific tissue distribution of CK1d
The CK1d positive reactivities in various paraffin embedded
tissues of young adult BALB/c mice obtained by immunohisto-
chemistry are summarised in Table 4 and correspond well with
our previous results obtained from Western blotting analyses [35].
Subcellular antigen distribution. In most immunoreactive
cells CK1d expression was restricted to the cytoplasm. Only in
Table 3. Effect of different blocking reagents on background reduction of CK1d immunostained frozen sections.
blocking solution specific against background reduction
Levamisole endogenous alkaline phosphatase ++
peroxidase-blocking reagens (DAKO) endogenous peroxidase ++
Uni-Block (BioGenex) endogenous biotin +++
Avidin/Biotin Blocking Kit (Zymed) +
blocking solution unspecific against background reduction
Aurion BSA-c, (Biotrend) hydrophobic and electrostatic interactions 2
Power Block, Casein (BioGenex) 2
anti- IgG F(ab9)2-fragment background reduction
N Anti-Rabbit IgG F(ab9)2 biotinylated (DAKO) 2
Frozen tissue sections were immunostained for CK1d in the presence and absence of the indicated blocking reagens. 2 no effect of the blocking reagens; + low
background reduction; ++ medium background reduction; +++ strong background reduction.
doi:10.1371/journal.pone.0004174.t003
Figure 1. Specificity of the anti CK1d polyclonal rabbit serum
NC10. An immunoabsorption test for NC10 was used to show its
specificity in immunohistochemistry (IHC). Immersion fixation with
acetic formalin, alkaline phosphatase reaction, dye: newfuchsin. IHC was
performed on paraffin-embedded pancreatic tissue of a 5 week old
BALB/c mouse using NC10 (A) or NC10 preincubated with either a
control peptide (the p53 specific peptide MEESQSDISLELGGC, 0.1 mg
(B)) or with the specific blocking peptide used for immunisation of
rabbits (CGDMASLRLHAARQGARC, 0.1 mg) for 3 h at 4uC( C). The results
indicate that the antigenic peptide, but not the control peptide
competively inhibits CK1d binding. Magnification: 4006.
doi:10.1371/journal.pone.0004174.g001
Figure 2. Immunohistochemical detection of CK1d in skeletal
muscles of a six week old BALB/c mouse. Longitudinal section.
Perfusion fixation with Bouin. Peroxidase reaction, dye: DAB. A similar
CK1d staining pattern of the myofibrils was detected independent of
the antibody (NC10, 108, or ab10877). Specific antibody binding was
visualised by the peroxidase reaction using DAB as substrate-
chromogen. (A) NC10, immersion fixation with acid formalin; (B) 108,
perfusion fixation with Bouin; (C): ab10877 (Abcam), immersion fixation
with acid formalin. Magnification 1006. Using three different CK1d
specific antibodies only minor variations in the CK1d staining pattern
were observed. These could be explained by alterations in the
phosphorylation status of CK1d influencing the disposability of the
particular antigenous epitope and/or by differences in the recognition
of CK1d splice variants being differently expressed in those cases.
doi:10.1371/journal.pone.0004174.g002
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BALB/c mice.
Thymus
Thymocytes outer cortex ++
Thymocytes inner cortex 2
Medulla ++/2
Lymph node / MALT
Lymphoid blasts ++
lmyphocytes B-zone +/2
lmyphocytes T-zone ++/2
Spleen Refer to ref. [35]
Muscle cells
Scelletal ++/2
Cardiac ++/2
Smooth +/2
Vascular endothelium
Arteries ++
Veins +/2
Lymphatics +/2
High endothelial venoles +/2
Mesothelial cells ++
Connective tissue
Adipocytes (univacuolar, polyvacuolar) ++
Fibroblasts/fibrocytes +/2
Chondrocytes 2
Osteocytes, osteobasts 2
Alimentary tract
Esophageal squamous epithelium, (basal cell layer) 2
Esophageal squamous epithelium (stratum granulosum,
corneum)
+++
Stomach, chief cells +++
Stomach, parietal cells 2
Stomach, mucous neck cells +/+++
Intestine, absortive cells ++
Intestine, goblet cells 2
Intestine, paneth cells 2
Urinary tract
Glomeruar endothelial cells 2
Mesangial cells 2
Podocytes ++
Bowman capsule 2
Tubulus epithelium ++/+++
Collecting duct epithelium ++/+++
Urothelium, basal cells +
Urothelium, umbrella cells 2
Female genital tract
Oocytes 2
Immature ovarian follicle, follicular epithelium +++
Mature ovarian follicle, follicular epithelium +
Theka cells 2
fallopian tube +++
Uterus endometrium +++
Stroma cells 2/++
Male genital tract
Germinal cells, spermatogonia ++/+++
Spermatocytes +
Sertoli cells +
Leydig cells +++
Epidymis epithelium +++
Deferent duct epithelium +++
Prostate gland +++
Seminal vesicle +++
Salivary glands
Serous epithelial cells ++/+++
Mucous epithelial cells 2
Myoepithelium 2
Ductal epithelium ++/+++
Pancreas
Exocrine gland, acinar cells ++
Exocrine gland, duct epithelium +/2
Islets +++/++
Adrenal
Stratum granulosum +
Stratum fasciculatum +
x-zone ++
Medulla ++/+
Hypophysis
Adenohypophysis +++
Neurohypophysis +++
Pars intermedia +++
Liver, gallbladder
Hepatocytes ++
Intrahepatic bile ducts 2
Gallbladder, extrahepatic bile ducts 2
Thyroid gland
Follicular epithelium ++
Eye
Conjunctival epithelium, basal cell layer 2
Conjunctival epithelium, superficial cell layer +++
Sclera 2
Choroidea 2
Iris stroma 2
Iris posterior epithelial lining ++
Ciliary muscle +
Ciliary epithelium ++
Lens capsule 2
Cuboidal epithelium of the lens ++
Lens nucleus +++
Retina
Choroid 2
Retinal pigment epithelium +
Outer nuclear layer 2
Outer plexiform layer +
Inner nuclear layer ++
Table 4. cont.
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immunoreactivity was observed.
Alimentary tract. The epithelial cell layers of esophagus,
stomach, and intestine (small intestine and colon) showed CK1d
immunoreactivity (Figure 3A, B, C). The stratified squamous
epithelium lining the esophagus and the proximal part of the
murine stomach displayed a gradual increase of CK1d expression
from the stratum basale, which was CK1d negative compared to
the strongly CK1d positive stratum corneum. In the glandular part
of the stomach, CK1d was highly expressed in the chief cells
located at the base of the gastric glands while parietal cells were
negative. Mucous neck cells showed only faint CK1d staining in
the glandular isthmus (where they constitute the regenerative
pool), but gained strong CK1d positivity during their differ-
entiation to mucous secreting cells found at the pits of the mucosa
(Figure 3A). Absorptive epithelial cells of the intestinal villi and
regenerative cells at the mucosal crypts were equally CK1d
positive (Figure 3B). In contrast, goblet cells and Paneth cells did
not show any CK1d staining. An analogous picture was seen in the
Inner plexiform layer +
Ganglion cell layer +++
Nerve fibre layer +
Respiratory tract
Upper aerodigestive tract, squamous epithelium,
basal cell layer
2
Upper aerodigestive tract, squamous epithelium,
superficial cell layer
+++
Respiratory epithelium +++
Type 1 pneumocytes 2
Type 2 pneumocytes ++
Nervous system
Peripheral nervous system
Trigeminal ganglion
Nerve cell pericarium ++
Peripheral nerve fibre 2
Spinal ganglion
Nerve cell pericarium ++
Peripheral nerve fibre 2
Central nervous system
Spinal cord
Gray matter – nerve cell pericaryon +++
Gray matter neuropil +
White matter (+)
Brain
Nerve cell pericarium/neuropil
Cerebral neocortex ++/++
Hippocampus ++/++
Basal ganglia +/2
Hypothalamus +/2
Thalamus +/2
Midbrain +/2
Pons +/2
Medulla oblongata +/2
Purkinje cells/cerebellum ++
Granule cells/cerebellum 2/2
Dentate nucleus +/2
White matter (+)
Skin and skin appendages
Epidermis (basal layer) 2
Epidermis (stratum granulosum, corneum) +++
Sebacous gland +++
Haderian gland +++
Mammary gland, glandular epithelium ++
Mammary gland, myoepithelium 2
Intensity levels of the CK1d specific staining were graded as 2 negative, + weak,
++ moderate, or +++ strong. Slash points to simultaneous expression of
different intensities, e.g., 2/++ indicates negative and moderately positive
staining in one cell type. Staining results were nearly identical independent of
the CK1d specific antibody (NC10, 108, or ab10877) having been used.
doi:10.1371/journal.pone.0004174.t004
Table 4. cont.
Figure 3. Immunohistochemical detection of CK1d in the
gastrointestinal tract, endocrine glands, lung, skin, and
mammary gland. Fixative: acid formalin, fixation by immersion.
Peroxidase reaction, dye: DAB. Immunohistochemical staining of CK1d
in the stomach (A); small intestinal (B); colon (C); large salivary gland
(D); small salivary gland of the trachea (E); pancreas (F); liver (G);
adrenal gland (H); thyroid gland (I); squamous epithelium of upper
aerodigestive tract (J); lung (K, L), skin (M), harderian gland (N), and
mammary gland (O). In (A), solid arrows point to parietal cells, open
arrows to neck parietal cells and open arrowheads to chief cells. In
figure 3L, solid arrows point to strong CK1d positive type II
pneumocytes. Magnification: 1006(A, B, K), 2006(G, H, J, N), 4006
(C–F, I, L, M, O).
doi:10.1371/journal.pone.0004174.g003
IHC Analysis of CK1d
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high amounts of CK1d, while goblet cells were negative
(Figure 3C).
Salivary glands and exocrine pancreas. The major
salivary glands, i.e. the parotid, the sublingual and the
submandibular glands, as well as the minor salivary glands of
the oropharynx, the esophagus and the upper respiratory tract all
expressed CK1d, albeit to a different extent (Figure 3D, E). As a
general pattern, mucous and myoepithelial cells were CK1d
negative, while serous epithelial cells and the salivary duct
epithelium expressed intermediate to high levels of CK1d.A
somewhat diverging picture was seen in the exocrine part of the
pancreas (Figure 3F). Here, the acinar cells showed moderate
CK1d positivity whereas the ductal epithelium was CK1d negative
to faintly positive.
Liver. In the liver (Figure 3G), a moderate CK1d immuno-
staining was found in the hepatocytes. CK1d expression in liver
cells was evenly distributed throughout the hepatic lobule. The
cytoplasm facing the sinusoids and the adjacent cell membrane
seemed to be the most intensely stained part of the hepatocytes.
This staining pattern might have obscured CK1d expression by
Kupffer cells, which was not detected. Expression of CK1d could
not be detected in the epithelium of the bile ducts and the
gallbladder.
Endocrine organs. The thyroid follicular epithelium showed
moderate CK1d staining (Figure 3I). Pancreatic islets harboured a
large population of strongly CK1d positive cells and a smaller
fraction of endocrine cells with moderate CK1d expression
(Figure 3F). In the adrenal cortex, low amounts of CK1d were
detected in the zona glomerulosa and the zona fasciculata while
cells of the x-zone showed moderate CK1d expression. Weak to
moderate staining was detected in the adrenal medulla (Figure 3H).
The expression pattern of CK1d in the pituitary gland is described
in the section ‘‘Peripheral and central nervous system’’.
Respiratory tract. The stratified squamous epithelium of the
upper aerodigestive tract displayed strong CK1d expression in the
basal cell layer and decreasing immunoreactivity towards the
superficial layers (Figure 3J). Strong cytoplasmic CK1d staining
was observed in the ciliated epithelium of the trachea and the
bronchial tree (Figure 3K). At the peripheral parts of the
respiratory tract, CK1d staining was lost upon transition from
bronchioles to the respiratory spaces (Figure 3K, L). However,
while flat alveolar epithelium cells (type I pneumocytes) were
CK1d negative, moderate CK1d staining was detected in cuboidal
type II pneumocytes (Figure 3L).
Skin and skin appendages. In accordance to the findings in
the esophagus, the keratinised squamous epithelium of the
epidermis displayed an increasing CK1d expression from the
weakly positive basal cell layer to the strongly CK1d positive
stratum granulosum (Figure 3M). Intensive CK1d staining was
also detected in the sebaceous glands of the hair follicle and in the
harderian glands (Figure 3N). The mammary gland showed
moderate levels of CK1d expression in the columnar/cuboidal
glandular epithelium while the myoepithelial cells remained
negative (Figure 3O).
Urinary tract. In the renal glomerulum, moderate CK1d
expression was detected in large cells located predominantly in the
capsule of gomerulae, most likely representing podocytes
(Figure 4A). All other cell types of the glomerulum, including
the parietal cells of Bowman’s capsule, were CK1d negative. The
epithelial lining of the renal tubule and the collecting ducts
displayed moderate to strong CK1d immunoreactivity (Figure 4B).
The so called transitional epithelium covering the efferent urinary
tract from the renal pelvis to the urinary bladder was weakly
CK1d positive in the basal layer while the umbrella cells were
CK1d negative (Figure 4C and Table 4).
Female genital tract. No CK1d expression was detected in
the oocytes (Figure 4D). CK1d expression by granulosa cells was
dependent on the maturation stage of the ovarian follicle. At the
stage of the primary follicle, granulosa cells were strongly CK1d
positive. With advancing maturation, CK1d expression gradually
decreased until the antigen? was only faintly detectable in the
epithelium of the mature follicle. Theka cells of mature follicles
were CK1d negative. The columnar epithelium lining the oviducts
(Figure 4E) as well as the glandular epithelium of the endometrial
mucosa (Figure 4F) displayed strong CK1d immunoreactivity. A
fraction of endometrial stroma cells expressed moderate levels of
CK1d.
Male genital tract. CK1d expression was observed in male
germ cells at various stages of differentiation. Moderate to strong
staining characterised the spermatogonia located at the base of the
seminiferous tubule. Upon differentiation, CK1d expression was
Figure 4. Immunohistochemical detection of CK1d in the
urogenital tract. Fixative: acid formalin, fixation by immersion.
Peroxidase reaction, dye: DAB. The staining results of the CK1d specific
antiserum NC10 in organs of the urogenital tract are shown. (A, B)
kidney; (C) ureter; (D) ovary; (E) fallopian tube; (F) uterus; (G) testis; (H)
seminal duct and epididymis; (I) prostate; (J) seminal vesicle. The solid
arrow indicates a primary follicle in D. Magnification: 1006 (E, F, H),
2006(A, D, I, J), 4006(B, C, G), 6406(A).
doi:10.1371/journal.pone.0004174.g004
IHC Analysis of CK1d
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spermatocytes. Sertoli cells were weakly CK1d positive (Figure 4G).
In the interstitial space of the testis, strong CK1d immuno-
reactivity of Leydig cells was conspicuous. Epithelial cells of the
epididymis and the deferent duct expressed high amounts of CK1d
(Figure 4H) as well as the glandular epithelium of the prostate and
the seminal vesicles (Figure 4I, J). In the seminal vesicles, CK1d
staining was predominantly baso-lateral, probably due to
unstained secretion products located in the centre and the apical
parts of the cell body (Figure 4J).
Immobile cells of mesenchymal origin. Most striated
muscle cells of the skeletal system and the myocardium were
strongly CK1d positive, only a few cells did not show any CK1d
immunoreactivity (Figure 5A, B). In skeletal muscle fibers, a
heterogenous CK1d staining pattern was observed with irregular
band-like fields periodically arranged perpendicular to the long
axis of the myofibril (Figure 5A). Such distribution was not
apparent in cardiomyocytes that displayed a more diffuse CK1d
staining (Figure 5B). Notably, strong CK1d staining frequently
highlighted the intercalated discs in the myocardium. In contrast
to striated muscle cells, CK1d was only weakly expressed in
smooth muscle cells in various organs, for example in the muscular
layer of the intestinal wall (Figure 5C) and the lower urinary tract.
However, smooth muscle cells in the media of arterial and venous
blood vessels displayed practically no CK1d staining (Figure 5D,
E). CK1d was also detected in the vascular endothelium.
Endothelial cells of arteries showed strong CK1d reactivity,
whereas in veins, capillaries, lymphatics, and in high endothelial
venules of secondary lymphatic tissue the endothelium was
moderately to weakly stained or CK1d negative (Figure 5D–F).
Mesothelial cells at all sites, i.e. the peritoneum (Figure 5G), the
pericardium (Figure 5H), and the pleura (Figure 5I) showed
intermediate levels of CK1d expression. In connective tissues,
adipocytes of the univacuolar and polyvacuolar type were
moderately CK1d positive (Figure 5J). Fibroblasts and fibrocytes
were negative or weakly positive (Figure 3M, N). CK1d was
neither expressed in chondrocytes of hyalin cartilage (Figure 5K)
nor in osteocytes and osteoblasts (Figure 5L).
Hematopoietic and lymphoid organs. Hematopoietic cells
of the bone marrow were weakly to moderately CK1d positive
(Figure 6A). CK1d expression seemed to correlate with
immaturity, and down-modulation of the antigen was observed
during intermediate maturation stages, including megakaryocytes.
A more detailed assignment of CK1d expression to specific
differentiation steps and hematopoietic lineages could not be
achieved on the CK1d stained immunosections.
Immunohistochemistry revealed moderate CK1d expression by
juxtacortical thymocytes and a gradual downregulation of the
antigen towards the cortico-medullary junction (Figure 6B). Thus,
in the thymic cortex, loss of CK1d staining seemed to be
coincidental with T-cell maturation. In the medulla, CK1d was
expressed at moderate levels by a large fraction of cells. Owing to
the heterogeneity of this microcompartment, it was not possible to
positively identify T-lymphocytes in the thymic medulla on
morphological grounds. The expression of CK1d in the spleen
has been specified in a previous report [35]. In the lymph node,
substantial CK1d staining was detected in the cortex, the
paracortex, and the medulla (Figure 6C, D). All compartments
contained CK1d positive and CK1d negative lymphocytes. CK1d
expression in primary B follicles was slightly lower than in the T-
cell zone. However, secondary B follicles such as those in cecal
patches of the gut-associated lymphoid tissue revealed a markedly
elevated CK1d staining in germinal centres, due to an intense
expression by centroblasts (Figure 6E, F).
Eye. The squamous epithelium of the conjunctiva displayed
strong CK1d staining in the superficial layer while the basal layer
was CK1d negative. No CK1d was detected in the sclera or the
choroidea. Moderate CK1d expression was seen in the epithelial
part of the iris and the ciliary body (Figure 6G). The underlying
stroma, including the sphincter muscle showed weak CK1d
staining. The capsule of the lens lacked any CK1d expression
(Figure 6H, I). However, the elongated epithelial fibers
constituting the body of the lens were strongly CK1d positive.
Intermediate levels of CK1d staining were observed in the
cuboidal epithelium at the anterior surface of the lens (Figure 6H).
Retina. The ganglion cell layer and the inner nuclear layer,
i.e., the third and second neuron of the retina were strongly or
moderately CK1d positive, respectively (Figure 6I). Double
staining of CK1d and bIII-tubulin localised the CK1d positivity
Figure 5. CK1d expression in immobile cells of mesenchymal
origin. Fixative: acid formalin, fixation by immersion. Peroxidase
reaction, dye: DAB. CK1d specific antiserum: NC10. The CK1d
immunostaining results of striated muscle cells of the skeletal system
(A), the myocardium (B), and of smooth muscle cells of the intestinal
wall (C); aterial blood vessel (D); venous blood vessel (E); lymphatic
vessel (F); mesothelial cells of the peritoneum, (G) mesothelial cells of
the pericardium (H), mesothelial cells of the pleura (I), adipocytes of
white and brown fatty tissue (J), chondrocytes of the hyaline cartilage
(K) and osteocytes (L) are shown. In B, arrows indicate intercalated discs
of cardiomyocytes. Magnification: 2006(G, H, J), 4006(A–F, I, K, L).
doi:10.1371/journal.pone.0004174.g005
IHC Analysis of CK1d
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staining was also observed in the axons of retinal ganglion cells
which are located in the retinal fiber layer. No CK1d staining was
seen in the photoreceptors, namely the outer nuclear layer.
Peripheral and central nervous system. In the pituitary
gland a significant cytoplasmic CK1d expression was detected in
cells of the adenohypophysis, the pars intermedia, and the
neurohypophysis (Figure 7A, B).
The nerve cell perikarya of spinal and trigeminal ganglia exhibit
CK1d whereas the adjacent nerve fibers were not marked
(Figure 7C, D). The spinal cord neurons were strongly marked
whereas the grey matter neuropil and the white matter only faintly
exhibited CK1d (Figure 7E). There were high levels of CK1d
detectable in all layers of the neocortex, the olfactory bulb, and the
molecular and Purkinje-cell layer of the cerebellum (Figure 7F, G,
H). Neocortical neurons showed a strong cytoplasmic staining
whereas the neuropil was softly stained (Figure 7I). There was no
obvious staining of glial cells. In the hippocampal formation the
neurons of the sectors CA1, CA3 and CA4 were strongly labelled
(Figure 7E). In the cerebellum CK1d stained the molecular layer
and the Purkinje cell layer (Figure 7J, K). The granule cell layer
neurons were not marked. There was only a very light staining of
the neuropil in this layer. At the higher magnification levels it was
evident that the expression of CK1d in the molecular layer was the
result of the staining of the entire dendritic trees of the Purkinje
cells (Figure 7K). There was no labelling of Bergmann glia cells
detectable. In the dentate nucleus of the cerebellum the neuropil
was softly stained whereas some neurons were strongly CK1d
positive (Figure 7L). The white matter as seen in the corpus
callosum and the cerebellar white matter did not show high levels
of CK1d. Low levels of CK1d were found in the thalamus,
midbrain, pons and the medulla oblongata. In the thalamus there
was a very light staining of the neuropil. Some thalamic neurons
exhibited CK1d in the cytoplasm whereas other neurons were not
labelled. Hypothalamic nuclei showed varying levels of CK1d.
Some of these neurons, e.g. in the suprachiasmatic nulceus,
exhibited nuclear CK1d (Figure 7M).
The expression of CK1d in the spinal ganglia showed a strong
immunoreactivity of the perikaryons (Figure 7N), whereas in the
nerve fibres only a moderate to intermediate CK1d staining
intensity could be observed.
Discussion
CK1d plays an important role in the regulation of various
cellular processes [2,42]. However, many of its physiological
functions are still unknown. The present study was carried out to
determine the cell-specific tissue distribution of CK1d in young
adult BALB/c mice in order to obtain a better understanding of its
biological functions.
A widespread distribution of CK1d was detected in all frozen
and paraffin embedded tissues although the expression levels
differed among the analysed tissues and organs. However, the
ubiquitous expression profile of CK1d is consistent with previous
RNA and protein expression profiling of CK1d in different tissues
[17,26,35,37,38,43,44]. Our results provide an anatomical back-
bone for future studies targeting cell-type specific functions of
CK1d. Since not much is known about cell-type specific functions
of CK1d, the discussion will be focused on those organs in which
some cell-type specific functions of CK1d have already been
observed.
Endocrine tissue
The strong granular cytoplasmic staining of CK1d in the
hypophysis, especially of the adenohypohysis and neurohypoph-
ysis, suggests important roles in the regulation of hormone
secretion and storage. In this context it is worthwhile to notice
that the CK1 family members a and d have been localised to the
synaptosome [45,46]. They interact and phoshorylate several
SNARE proteins, among them SV-2, syntaxin and snapin [47–
49]. Phosphorylation of SNARE proteins has been suggested to
influence their interaction with other proteins as well as vesicle
transport and neurotransmitter release [48–55].
Moreover, the predominant distribution of CK1d in endocrine
tissues suggests critical roles in the regulation of hormone
secretion. These findings are in line with the postulated role of
CK1 family members in regulating vesicle budding and transport
processes [1,2,19,56,57].
In the pancreas, the islets of Langerhans were stained much
stronger than the exocrine portions including the duct system.
However, islet cells differed in their degree of CK1d expression.
Figure 6. Localisation of CK1d in hematopoetic and lymphoid
organs and the eye. Fixative: acid formalin, fixation by immersion.
Peroxidase reaction, dye: DAB. The CK1d specific antibody NC10 was
used to detect CK1d in hematopoetic and lymphoid organs and in the
eye. (A) bone marrow; (B) thymus; (C, D) lymph node; (E, F) cecal
lymphoid follicle; (G) the eye ciliary body and iris; (H) lens and iris; (I)
retina and lens. Immunohistochemical analysis of frozen retinal sections
reveals localisation of CK1d in retinal ganglion cells, which were
specifically co-stained with an anti-bIII-tubulin antibody or DAPI (J–L).
Magnification: 1006(B, C, E), 2006(D, F), 4006(A, G–L). ONL: outer
nuclear layer; INL inner nuclear layer; GCL: retinal ganglion cell layer.
Scale bar: 50 mm. Arrows in D indicate high endothelial venules (HEV),
arrows in E delineate a B-follicle. In F closed arrows point to a lymphoid
blast, the arrowhead points to a small resting lymphocyte and the open
arrow indicates high endothelial venule.
doi:10.1371/journal.pone.0004174.g006
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the secretory phase of endocrine cells. In particular, it could be
involved in the trafficking of secretory granules. On the other
hand, this might reflect that different types of hormone secreting
islet cells vary in their expression level of CK1d. CK1d expression
could also depend on the activity status of the hormone regulating
cells as hormone secretion relies on circadian periodicity.
Accordingly, differences in hormone production and in the
activity state of hormone producing cells might also explain the
heterogeneous cytoplasmic staining of CK1d of cells of the adrenal
and pituitary glands.
CK1d immunoreactivity was seen in the endocrine organs and
in the disseminated endocrine cells of the gastrointestinal tract. In
the testis, Leydig cells show a strong CK1d positive staining
suggesting a role of CK1d in transport and release of testerone [2].
Immune system
CK1d expression was seen in all lymphatic tissues. CK1d
positive lymphocytes were detected in the PALS and the marginal
zone of the splenic white pulp [35]. In secondary lymphatic organs
of the intestine, a high CK1 expression was observed in
lymphoblasts, indicating that CK1d is induced in an antigen-
specific manner. Thus, CK1d could play a role in modulating the
specific immune response.
Central nervous system
CK1d expression profiling in the brain indicated a broad
distribution of CK1d but differences in expression levels and
subcellular localisation were detected. These results are in line with
previous reports showing the expression of CK1d RNA and
protein in many different cerebral areas, e.g. in the striatum and
neocortex, cerebrellum, hippocampus, thalamus, olfactory bulb
and the midbrain region [17,24,43,58].
Figure 7. CK1d expression in the nervous system. Fixative: acid
formalin, fixation by immersion. Peroxidase reaction, dye: DAB. (A) CK1d
was strongly expressed in the hypophysis. (B) The high-power view
shows a cytoplasmatic staining of the epithelial cells of the
adenohypophysis (Adeno). The pars intermedia (PI) and the neurohy-
pophysis (N) were also strongly marked. (C, D): The nerve cell perikarya
of a spinal (C) and a trigeminal ganglion (D, arrow) exhibit CK1d
whereas the adjacent nerve fibers were not marked. (E) The spinal cord
neurons were strongly marked (arrows) whereas the gray matter
neuropil and the white matter only faintly exhibited CK1d (asterix). The
inset demonstrates the high power view into the boxed area and shows
a marked cytoplasmic labelling. (F) In the hippocampal formation the
neurons of the sectors CA1, CA2 and CA3 were strongly labelled
(arrows). (G) Sagittal section of a mouse brain immunostained with the
NC10 antibody directed against CK1d. There are especially high levels of
CK1d detectable in all layers of the neocortex (NC), the olfactory bulb
(OB), and the molecular and Purkinje-cell layer of the cerebellum (CB).
The white matter as seen in the corpus callosum (CC) and the cerebellar
white matter did not show high levels of CK1d. Low levels of CK1d were
found in the thalamus (THAL), midbrain (MB), pons (P) and the medulla
oblongata (MO). (H, I) At higher magnification neocortical neurons
show a strong cytoplasmatic staining whereas the neuropil was weakly
stained. There was no staining of glial cells detectable. (J) In the
thalamus there was a very light staining of the neuropil. Some thalamic
neurons exhibited CK1d in the cytoplasm (arrows) whereas other
neurons were not labelled (arrowheads). (K) In the cerebellum CK1d
stained the molecular layer (M) and the Purkinje cell layer (P). The
granule cell layer neurons (G) were not marked. There was only a very
light staining of the neuropil in this layer. (L) At the higher
magnification levels it was evident that the CK1d expression in the
molecular layer was the result of the staining of the entire dendritic
trees of the Purkinje cells. The arrows indicate a Purkinje cell with the
apical dendrite positive for CK1d. There was no labelling of Bergmann
glia cells. (M) In the dentate nucleus of the cerebellum the neuropil was
weakly stained whereas some neurons were strongly CK1d positive
(arrows). Neurites were also labelled in this nucleus (arrowheads).
Hypothalamic nuclei showed varying levels of CK1d. Some of these
neurons, e.g. in the suprachiasmatic nulceus exhibited nuclear CK1d.N .
supraopticus (N). Calibration bar in L equals: A=270 mm, B=120 mm,
C, H, L, N=180mm, D=150mm, E=400mm, E-inset=55mm
F=280 mm, G=800 mm, I=6.6 mm, J, M=40mm, K=70mm. CK1d
was stained with the antibodies NC10 (A–C, E–N) and abcam 10877 (D).
doi:10.1371/journal.pone.0004174.g007
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supraopticus which is a bilateral nucleus in the anterior
hypothalamus involved in the regulation of the circadian rhythm.
The neurons in this area showed, in addition to the cytoplasmic
labelling, a strong nuclear CK1d staining. These results are in line
with previous observations [17] demonstrating that CK1d
modulates the stability, activity and nuclear entry of various
‘‘clock’’ proteins participating in the regulation of the circadian
rhythm (reviewed in [27,59]).
A strong CK1d staining of the pericarya of neurons of the spinal
cord, the hippocampus, the cerebrellum, the neocortex and the
olfactory bulb were observed, whereas a heterogenous CK1d
positivity was seen in neurons of the thalamus. In each case a
weaker CK1d positivity of the neuropil was observed. Further-
more, a strong staining of the entire dendritic cells was seen. These
observations might point to regulatory functions of CK1d in
neuronal signal transduction, especially in glutamatergic transmis-
sion pathways [43,44]. The dendritic localisation of CK1d might
indicate a role of CK1d in regulating neurite outgrowth, dendritic
plasticity and stability by modulating the dynamic of both, the
microtubule and the actin network. A possible function in
regulating microtubule dynamics is further supported by the fact
that CK1d associates with and phosphorylates a/b-tubulin as well
as microtubule associated proteins, like MAP1A, MAP4, tau,
stathmin and APC ([2] and references therein, [61]). Deregulation
of CK1d has been shown to be associated with neurodegenerative
diseases. CK1d co-localises with granulovacuolar inclusions and
tau-containing neurofibrillary tangles in Alzheimer’s disease,
Down syndrome, and Parkinson’s disease. In Alzheimer’s disease
the co-localisation of CK1d with tau points to a function for CK1d
in the abnormal processing/phosphorylation of tau [23,24,62–65].
The neurological breakdown in Parkinson’s disease is predomi-
nantly correlated with the progressive degeneration of dopami-
nergic neurons. CK1d has a regulatory role in dopaminergic
neurotransmission, e. g. the CK1d dependent activation of
glutamate receptors results in high CK1 kinase activities in
neostriatal neurons, leading to enhanced phosphorylation of
DARPP-32 [43,44].
Reproductive organs
The pattern of CK1d expression in the testis, i.e., a strong
positivity in spermatogonia located at the base of the seminiferous
tubules, might indicate a role in meiotic cell division. In fact,
several CK1 isoforms have been shown to be important for
accurate chromosome segregation during meiosis [20,21,66]. In
addition, CK1d might be required for the survival and
development of germ cells. The ability of CK1d to phosphorylate
and/or to associate with motor proteins, AKAP proteins, MAPs,
tubulin and actin binding proteins (reviewed in [2]) indicates its
involvement in reorganising the cytoskeleton in spermatogonia.
CK1d might also be involved in the regulation of various
processes in Sertoli cells, which provide structural and metabolic
support to developing germ cells to which they are connected
through multiple tight junctions. CK1d has been shown to be
associated with several tight junction proteins [67,68] and could
therefore be involved in regulating the dynamic reforming of tight
junctions.
In conclusion, CK1d is ubiquitously distributed in adult
tissues, since phosphorylation events mediated by CK1d could
play an important role in regulating numerous tissue and organ
specific processes. The dynamics of phosphorylation/dephos-
phorylation events may account for the extremely variable CK1d
expression pattern. In general, the expression level of CK1d
seems to depend on several parameters, such as the functional
status, differentiation stage or gender. However, our profiling of
CK1d expression provides an anatomical backbone for future
studies targeting cell-type specific functions of CK1d in various
tissues and organs.
Materials and Methods
Animals and Tissue Processing
BALB/c mice were bred in the Animal Facility of the Heinrich-
Pette-Institute, Hamburg, and in the Animal Research Centre at
the University of Ulm, Germany. All animal procedures
conformed to institutional and European regulations concerning
the protection of animals.
Tissue samples from 4 to 6 week old BALB/c female and male
mice were immediately removed after killing and either shock-
frozen or fixed by immersion in either 1% acetic acid in formalin,
10% buffered neutral formalin, zinc fixative [69], zinc-Formal-
Fixx
TM (Thermo Scientific, Fremont, CA, USA), NOTOX
TM
(Quartett, Berlin, Germany), Glyo-Fixx
TM (Thermo Scientific,
Fremont, CA,, USA), Bouin’s or Carnoy’s fixatives [70]. Alterna-
tively, the animals weredeeply anesthetized with Ketamin and fixed
by cardiac perfusion with one of the following fixatives: 10%
buffered neutral formalin, 1% acetic acid in formalin or Bouin’s
solution (see also Table 1). Bone tissue was decalcified with EDTA
for several days at 4uC. Fixed tissues were then dehydrated in a
graded ethanol series, cleared in methyl benzoate, and embedded in
paraffin. Paraffin-embedded sections were cut at 3 mma n d
mounted on glass slides. Frozen tissue was embedded in Tissue-
Tek (Sakura, Heppenheim, Germany). Sections (5–8 mm) were cut
on a cryostat microtom (Leica, Bensheim, Germany), mounted on
dry glass slides and fixed in 100% acetone for 10 min at 4uC.
Primary antibodies
For IHC the CK1d-specific polyclonal antisera NC10 (rabbit)
[19], 108 (rabbit) [36] and ab10877 (goat) (abcam, Cambridge,
GB) were used (see also Figure 2). The specificity of the rabbit
antiserum 108 for IHC analysis was validated previously [36]. The
specificity of NC10 was tested by immunoabsorption in immuno-
histochemistry using either the synthetic oligopeptide against
which the antibody was raised, or an unrelated p53 specific
oligopeptide (see Figure 1).
Immunohistochemistry
Staining of paraffin sections. Staining procedures included
deparaffinization in xylene, followed by rehydration via transfer
through graded alcohols. To inhibit endogenous enzyme activity,
Peroxidase Blocking Reagent (DAKO, Glostrup, Denmark) or
Levamisole (DAKO, Glostrup, Denmark) were used. The sections
were treated with different antigen retrieval solutions (Citra Plus
(BioGenex, San Ramon, CA, USA), pH 6.03; AR-10 Solution
(BioGenex,SanRamon,CA,USA),pH 10.7;Trisbuffer,pH 7.3as
well as TUF solution, pH 5.7 (Kreatech, Amsterdam, Netherlands))
in a microwave oven, according to the manufacturer’s instructions
(see also Table 2). Sections were then incubated with one of the
CK1d specific antibodies (NC10, 1:1200; 108, 1:1200; ab10877,
1:1600) at 4uC overnight. After washing in Tris-HCl buffer a
horseradish peroxidase containing polymer conjugated anti-rabbit
or anti-goat IgG antibody (N-Histofine
R, Nichirei Corporation,
Tokio, Japan), or alkaline phosphatase containing polymer coupled
anti-rabbit IgG (N-Histofine
R, Nichirei Corporation, Tokio, Japan)
was applied at room temperature (RT) for 30 minutes. The
enzymatic reaction was developed in a freshly prepared solution
of 3, 39-diaminobenzidine using DAKO Liquid DAB Substrate-
Chromogen solution as a chromogen for horseradish peroxidase or
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Denmark) for alkaline phosphatase. The sections were then
counterstained with hematoxylin and permanently mounted in
Entellan (Merck, Darmstadt, Germany). Positive and negative
controls were included for each case. As a negative control the
primary antiserum was omitted and substituted with Tris-HCl
buffer.
Staining of frozen sections. Frozen sections were quickly
rehydrated in Tris-HCl buffer. Endogenous enzyme activity was
blocked as described above. Sections were then incubated with
either NC10 (1:400), 108 (1:400) or ab10877 (1:200) for
40 minutes at RT. Slides were washed in Tris-HCl buffer and
the DAB or Newfuchsine reaction performed as described above.
Next, sections were counterstained with hematoxylin.
Immunofluorescence analysis of frozen tissue
Eyes separated from connective tissue after perfusion fixation
with PBS containing 14% paraformaldehyde were post-fixed for
several hours, transferred to 30% sucrose overnight (4uC) and
embedded in Tissue-Tek (Sakura, Heppenheim, Germany).
Cyrosections were prepared as described above. Sections were
labelled with monoclonal antibodies against bIII-tubulin (1:2000,
TUJ-1, Babco, Richmond, CA, USA) and against CK1d (NC10,
1:200). Secondary antibodies included anti-mouse IgG, anti-rabbit
IgG and anti-sheep IgG antibodies conjugated to Alexa Fluor 488
and Alexa Fluor 594 (1:1,000; Molecular Probes, Paisley, UK). For
nuclear staining, sections were incubated in a solution containing
49,6-diamidino-2-phenylindol (DAPI) for 2 minutes. Fluorescently
labelled sections were embedded in Moviol (Calbiochem,
Darmstadt, Germany) and analysed under a fluorescent micro-
scope (Axioplan2, Zeiss, Jena, Germany).
Grading System
Sections were graded with regard to intensity of the CK1d
specific staining. Intensity levels of the CK1d specific staining were
graded as 2 negative, + weak, ++ moderate, or +++ strong. Slash
points to simultaneous expression of different intensities, e.g., 2/
++ indicates negative and moderately positive staining in one cell
type or brain region.
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